Cancer Treatment Centers of America
For almost 30 years Cancer Treatment Centers of America (CTCA) has been dedicated to finding the “right combination of personalized cancer treatment for patients.” CTCA works with patients and their medical staff and caregivers to develop an integrated treatment plan, utilizing a team of oncologists, surgeons, and other specialists as a means of developing more effective therapy methods. Treatments endorsed by CTCA include improved radiation therapy, new targeted drug therapies, and minimally invasive surgical procedures. Other avenues include immunity supporting therapies, as well as improving patient quality of life. CTCA currently has hospitals in the Chicago area, Philadelphia, Phoenix, Tulsa, and a hospital opening soon in the Atlanta area.
The CTCA’s treatment philosophy originated in the early 1980s following the death of founder Richard J. Stephenson’s mother, Mary Brown Stephenson. Following Mary’s Diagnosis, Richard Stephenson sought out advanced and effective cancer treatments. What the Stephenson family discovered was that treatments focused on clinical and technical aspects of the disease but failed to meet the individual needs of the patients. In the spirit and memory of his mother, Richard vowed to change the current approach to cancer care, challenging a group of oncologists to deliver “whole-person cancer treatment in a compassionate, nurturing environment.”
CTCA is comprised of a national network of full-accredited hospitals and medical centers that have earned the Full Standards Compliance from the Joint Commission. These facilities provide state-of-the-art health and cancer care with a focus on healing. CTCA refers to their approach as the Mother Standard® of care, offering the kind of care staff would want for their own families, driven by advanced whole-person treatment options. Care includes the coordination of traveling and lodging so patients and their loved ones can focus on their healing.
CTCA has a wealth of achievements and accreditations, including the American College of Radiology, the Joint Commission, the College of American Pathologists, and the Association of Community Cancer Centers to name a few. CTCA is also approved by the United States Food and Drug Administration, as well as being recognized as a “leader in patient care and safety.”